June 23, 2026
8 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
For decades, biologics have been the gold standard for psoriasis treatment. Now, the psoriasis therapeutic landscape is transforming with new medications that approach biologic-level efficacy in pill form.“Psoriasis care has changed dramatically over the last 20 years,” April Armstrong, MD, MPH, chief of the division of dermatology at UCLA Health and an investigator for several
June 23, 2026
8 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

A therapy that works similarly to AbbVie’s blockbuster Skyrizi appeared more potent in a mid-stage trial and has the potential to…

Nearly half of patients with psoriasis screened for cardiovascular disease risk factors at the recommendation of their…

Pyoderma gangrenosum is a difficult-to-treat wound disease that may soon have promising new therapies.In this Beneath the Surface…

The novel interleukin-17AA targeted molecule izokibep showed ACR50 response rates of more than 50% in psoriatic arthritis at 52…

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss…